Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-28 Sale |
2022-03-02 9:11 pm |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
21,533 | $2.1659 | $46,637 | 497,017 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 9:10 pm |
Akebia Therapeutics Inc. | AKBA | Faulkingham Dell SVP, CCO |
13,184 | $2.1629 | $28,515 | 373,841 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 9:10 pm |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
21,062 | $2.1658 | $45,615 | 504,241 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 9:09 pm |
Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer |
8,203 | $2.1564 | $17,689 | 353,599 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 4:11 pm |
Akebia Therapeutics Inc. | AKBA | Cotreau Violetta SVP, Chief Accounting Officer |
5,833 | $2.2862 | $13,335 | 33,067 (Direct) |
View |
| 2021-08-31 Sale |
2021-09-02 4:07 pm |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
1,042 | $2.83 | $2,949 | 171,219 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-09 4:26 pm |
Akebia Therapeutics Inc. | AKBA | GILMAN STEVEN C Director |
4,567 | $3.3202 | $15,163 | 47,997 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-01 8:35 pm |
Akebia Therapeutics Inc. | AKBA | Faulkingham Dell SVP, CCO |
952 | $3.4 | $3,237 | 137,025 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-01 8:34 pm |
Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer |
790 | $3.4 | $2,686 | 76,802 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-01 8:33 pm |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
1,060 | $3.4 | $3,604 | 272,303 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-01 8:33 pm |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
1,211 | $3.4 | $4,117 | 265,550 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-01 8:32 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
4,109 | $3.4 | $13,971 | 1,534,103 (Indirect Direct) |
View |
| 2021-04-01 Sale |
2021-04-01 8:31 pm |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
1,081 | $3.4 | $3,675 | 170,761 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:10 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
49,990 | $3.3961 | $169,771 | 1,902,292 (Indirect Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:08 pm |
Akebia Therapeutics Inc. | AKBA | Faulkingham Dell CCO |
6,749 | $3.3961 | $22,920 | 238,825 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:08 pm |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
14,285 | $3.3961 | $48,513 | 373,171 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:08 pm |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
14,547 | $3.3961 | $49,403 | 365,113 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:06 pm |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
7,558 | $3.3961 | $25,668 | 281,442 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-28 Option Award |
2022-03-02 9:11 pm |
N/A 2032-02-28 |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
250,000 | $0 | 497,017 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:10 pm |
N/A 2032-02-28 |
Akebia Therapeutics Inc. | AKBA | Faulkingham Dell SVP, CCO |
250,000 | $0 | 373,841 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:10 pm |
N/A 2032-02-28 |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
250,000 | $0 | 504,241 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:09 pm |
N/A 2032-02-28 |
Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer |
285,000 | $0 | 353,599 (Direct) |
View |
| 2021-11-01 Option Award |
2021-11-03 4:47 pm |
N/A 2031-11-01 |
Akebia Therapeutics Inc. | AKBA | FRIESON RON Director |
80,200 | $0 | 80,200 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-01 4:06 pm |
N/A 2031-09-30 |
Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-03 5:28 pm |
2022-06-02 2031-06-02 |
Akebia Therapeutics Inc. | AKBA | Wolf Myles Director |
33,800 | $0 | 44,081 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-03 5:27 pm |
2022-06-02 2031-06-02 |
Akebia Therapeutics Inc. | AKBA | Smith Cynthia Director |
33,800 | $0 | 71,633 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-03 5:27 pm |
2022-06-02 2031-06-02 |
Akebia Therapeutics Inc. | AKBA | ROGERS MICHAEL W Director |
33,800 | $0 | 72,429 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-03 5:27 pm |
2022-06-02 2031-06-02 |
Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director |
33,800 | $0 | 111,200 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-03 5:27 pm |
2022-06-02 2031-06-02 |
Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director |
33,800 | $0 | 68,686 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-03 5:26 pm |
2022-06-02 2031-06-02 |
Akebia Therapeutics Inc. | AKBA | GILMAN STEVEN C Director |
33,800 | $0 | 72,664 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 7:19 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer |
7,592 | $0 | 77,592 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 7:18 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | Faulkingham Dell CCO |
9,152 | $0 | 137,977 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 7:18 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
10,192 | $0 | 273,363 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 7:17 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
11,648 | $0 | 266,761 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 7:17 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
39,520 | $0 | 1,538,212 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 7:16 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
10,400 | $0 | 171,842 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:10 pm |
N/A 2031-02-26 |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
641,000 | $0 | 1,902,292 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:08 pm |
N/A 2031-02-26 |
Akebia Therapeutics Inc. | AKBA | Faulkingham Dell CCO |
172,000 | $0 | 238,825 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:08 pm |
N/A 2031-02-26 |
Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer |
172,000 | $0 | 373,171 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:08 pm |
N/A 2031-02-26 |
Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer |
172,000 | $0 | 365,113 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:06 pm |
N/A 2031-02-26 |
Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer |
190,000 | $0 | 281,442 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:06 pm |
N/A 2031-02-26 |
Akebia Therapeutics Inc. | AKBA | Cotreau Violetta SVP, Chief Accounting Officer |
70,200 | $0 | 83,100 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:05 pm |
N/A 2031-02-26 |
Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer |
190,000 | $0 | 190,000 (Direct) |
View |
| 2021-02-16 Option Award |
2021-02-18 08:17 am |
N/A 2031-02-16 |
Akebia Therapeutics Inc. | AKBA | ZUMWALT LEANNE M Director |
80,200 | $0 | 80,200 (Direct) |
View |
Ownership |
2021-01-28 5:03 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | Cotreau Violetta SVP, Chief Accounting Officer |
0 | $0 | 54,900 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:08 pm |
N/A 2030-06-30 |
Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer |
280,000 | $0 | 280,000 (Direct) |
View |